drugset / Trial / NCT07096830

Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing

NCT07096830

Not yet recruiting 66 enrolled Fazeelat Bibi
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a single-center, randomized controlled trial evaluating the effectiveness of topical tetrachlorodecaoxide (TCDO) solution in enhancing chronic wound healing. The study will compare standard wound care with and without the addition of topical TCDO drops. Eligible adult participants with chronic wounds of more than six weeks' duration will be randomly assigned to either the intervention or control group. The trial aims to assess the rate of wound healing, time to 50% wound closure, pain reduction measured by the Visual Analog Scale (VAS), and cost-effectiveness.

Timeline

Start
2025-08-30
Primary completion
2026-07-30
Completion
2026-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject WF10 Other / unclassified Topical

Indications